Do screening-preventative interventions in asymptomatic pregnancies reduce the risk of preterm delivery-A critical appraisal of the literature

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 127, Issue 2, 2006, Pages 145-159

  Varma, Rajesh ^a   Gupta, Janesh K ^a   James, David K ^b   Kilby, Mark D ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Bacterial; Cerclage; Cervical incompetence; Cervix; Fibronectins; Glucocorticoids; Labour; Premature; Prevention; Progesterone; Tocolysis; Vaginosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ASCORBIC ACID; ATOSIBAN; CALCIUM; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; FIBRONECTIN; FISH OIL; HYDROXYPROGESTERONE CAPROATE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; METRONIDAZOLE; NIFEDIPINE; OMEGA 3 FATTY ACID; PREDNISONE; PROGESTERONE; ROFECOXIB; TRACE ELEMENT; UTERUS SPASMOLYTIC AGENT; VITAMIN; ZINC;

ANTIPHOSPHOLIPID SYNDROME; ASYMPTOMATIC BACTERIURIA; BACTERIAL TRANSMISSION; CHLAMYDIASIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORRELATION ANALYSIS; DRUG WITHDRAWAL; ECHOGRAPHY; EVIDENCE BASED PRACTICE; FIRST TRIMESTER PREGNANCY; GENITAL TRACT INFECTION; GLUCOSE INTOLERANCE; GRAM NEGATIVE INFECTION; HIGH RISK PREGNANCY; HORMONAL THERAPY; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LIFESTYLE; LOW BIRTH WEIGHT; MEDICAL LITERATURE; META ANALYSIS; MULTIPLE PREGNANCY; PATENT DUCTUS ARTERIOSUS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; PRENATAL DIAGNOSIS; PREVENTION AND CONTROL; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SMOKING CESSATION; SOCIAL PSYCHOLOGY; STREPTOCOCCUS INFECTION; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; TREATMENT OUTCOME; URINARY TRACT INFECTION; UTERINE CERVIX CERCLAGE; UTERINE CERVIX INCOMPETENCE; VAGINITIS; WORK ENVIRONMENT;

EID: 33747046693     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.02.001     Document Type: Review

References (155)

1. Moutquin J.M. Classification and heterogeneity of preterm birth. Br J Obstet Gynaecol: Int J Obstet Gynaecol 110 (2003) Suppl-3
2. Slattery M.M., and Morrison J.J. Preterm delivery. Lancet 360 9344 (2002) 1489-1497
3. Ward R.M., and Beachy J.C. Neonatal complications following preterm birth. Br J Obstet Gynaecol 110 Suppl 20 (2003) 8-16
4. Institute for Clinical Systems Improvement (ICSI). Preterm Birth Prevention, ICSI Health Care Guideline (2003), Institute for Clinical Systems Improvement (ICSI), Bloomington, MN
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists, Number 31. Obstet Gynecol 98 4 (2001) 709-716
6. Iams J.D. Prediction and early detection of preterm labor. Obstet Gynecol 101 2 (2003) 402-412
7. El Bastawissi A.Y., Sorensen T.K., Akafomo C.K., Frederick I.O., Xiao R., and Williams M.A. History of fetal loss and other adverse pregnancy outcomes in relation to subsequent risk of preterm delivery. Matern Child Health J 7 1 (2003) 53-58
8. Carlini L., Somigliana E., Rossi G., Veglia F., Busacca M., and Vignali M. Risk factors for spontaneous preterm birth: a Northern Italian multicenter case-control study. Gynecol Obstet Invest 53 3 (2002) 174-180
9. Adams M.M., Elam-Evans L.D., Wilson H.G., and Gilbertz D.A. Rates of and factors associated with recurrence of preterm delivery. JAMA 283 12 (2000) 1591-1596
10. Airoldi J., Berghella V., Sehdev H., and Ludmir J. Transvaginal ultrasonography of the cervix to predict preterm birth in women with uterine anomalies. Obstet Gynecol 106 3 (2005) 553-556
11. National Institute of Clinical Excellence U. NICE Clinical Guideline - antenatal care - routine care for healthy pregnant women; 2003.
12. Ehrenberg H.M., Dierker L., Milluzzi C., and Mercer B.M. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol 189 6 (2003) 1726-1730
13. Berkman ND, Thorp JM, Hartmann KE, Idicula AE, McPheeters M, Gavin NI, et al. Management of preterm labor. Evidence Report/Technology Assessment, Number 18, AHRQ Publication No. 01-E021. Agency for Healthcare Research and Quality, Rockville, USA; 2000.
14. Lu M.C., Tache V., Alexander G.R., Kotelchuck M., and Halfon N. Preventing low birth weight: is prenatal care the answer?. J Mater Fetal Neonatal Med 13 6 (2003) 362-380
15. Lumley J., Oliver S., and Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 4 (2005)
16. Armstrong M.A., Gonzales O.V., Lieberman L., Carpenter D.M., Pantoja P.M., and Escobar G.J. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 23 1 (2003) 3-9
17. Little B.B., Snell L.M., Van Beveren T.T., Crowell R.B., Trayler S., and Johnston W.L. Treatment of substance abuse during pregnancy and infant outcome. Am J Perinatol 20 5 (2003) 255-262
18. Sweeney P.J., Schwartz R.M., Mattis N.G., and Vohr B. The effect of integrating substance abuse treatment with prenatal care on birth outcome. J Perinatol 20 4 (2000) 219-224
19. Xiong X., Buekens P., Alexander S., Demianczuk N., and Wollast E. Anemia during pregnancy and birth outcome: a meta-analysis. Am J Perinatol 17 3 (2000) 137-146
20. Rasmussen K. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth. Length of gestation and perinatal mortality?. J Nutr 131 2 Suppl 2 (2001) 590S-601S
21. Villar J., Merialdi M., Gulmezoglu A.M., et al. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials. J Nutr 133 5 Suppl 2 (2003) 1606S-1625S
22. Cogswell M.E., Parvanta I., Ickes L., Yip R., and Brittenham G.M. Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr 78 4 (2003) 773-781
23. Friis H., Gomo E., Nyazema N., et al. Effect of multimicronutrient supplementation on gestational length and birth size: a randomized, placebo-controlled, double-blind effectiveness trial in Zimbabwe. Am J Clin Nutr 80 1 (2004) 178-184
24. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 4 (2005)
25. Bachmann L.M., Coomarasamy A., Honest H., and Khan K.S. Elective cervical cerclage for prevention of preterm birth: a systematic review. Acta Obstet Gynecol Scand 82 5 (2003) 398-404
26. Drakeley A.J., Roberts D., and Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women. Cochrane Database Syst Rev 4 (2005)
27. Odibo A.O., Elkousy M., Ural S.H., and Macones G.A. Prevention of preterm birth by cervical cerclage compared with expectant management: a systematic review. Obstet Gynecol Survey 58 2 (2003) 130-136
28. MRC RCOG. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol 100 6 (1993) 516-523
29. Guise J.M., Mahon S.M., Aickin M., Helfand M., Peipert J.F., and Westhoff C. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 20 3 Suppl (2001) 62-72
30. Honest H., Bachmann L.M., Knox E.M., Gupta J.K., Kleijnen J., and Khan K.S. The accuracy of various tests for bacterial vaginosis in predicting preterm birth: a systematic review. Br J Obstet Gynecol 111 5 (2004) 409-422
31. Lamont R.F. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. Br J Obstet Gynaecol: Int J Obstet Gynaecol 110 (2003) Suppl-5
32. McDonald H., Brocklehurst P., Parsons J., and Vigneswaran R. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 4 (2005)
33. Riggs M.A., and Klebanoff M.A. Treatment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol 47 4 (2004) 796-807
34. Leitich H., Brunbauer M., Bodner-Adler B., Kaider A., Egarter C., and Husslein P. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 188 3 (2003) 752-758
35. Guise J.M., Mahon S.M., Aickin M., Helfand M., Peipert J.F., and Westhoff C. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 20 3 Suppl (2001) Suppl-72
36. Okun N., Gronau K.A., and Hannah M.E. Antibiotics for bacterial vaginosis or trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 105 4 (2005) 857-868
37. Varma R., and Gupta J.K. Antibiotic treatment of bacterial vaginosis in pregnancy: multiple meta-analyses and dilemmas in interpretation. Eur J Obstet Gynecol Reprod Biol 124 1 (2006) 10-14
38. Lamont R.F. Can antibiotics prevent preterm birth-the pro and con debate. Br J Obstet Gynaecol 112 Suppl 1 (2005) 67-73
39. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342 8 (2000) 534-540
40. Kiss H., Petricevic L., and Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 329 7462 (2004) 371
41. Klebanoff M.A., Carey J.C., Hauth J.C., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345 7 (2001) 487-493
42. Gulmezoglu A.M., and Cochrane Pregnancy and Childbirth Group. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 4 (2005)
43. Andrews W.W., Goldenberg R.L., Mercer B., et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 183 3 (2000) 662-668
44. Martin D.H., Eschenbach D.A., and Cotch F.A. Double-blind placebo controlled treatment trial of chlamdyia trachomatis endocervical infections in pregnant women. Inf Dis Obstet Gynecol 5 (1997) 10-17
45. Raynes-Greenow C.H., Roberts C.L., Bell J.C., Peat B., and Gilbert G.L. Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev 4 (2005)
46. RCOG. Prevention of Early Onset Neonatal Group B Streptococcal Disease, No. 36 (November 2003), RCOG Press, London
47. Klebanoff M.A., Regan J.A., Rao A.V., et al. Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol 172 5 (1995) 1540-1545
48. Schrag S., Gorwitz R., Fultz-Butts K., and Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51 RR-11 (2002) 1-22
49. Canadian Task Force on Preventive Health Care. Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Fam Phys 48 (2002) 934-936
50. Goldenberg R.L., Iams J.D., Das A., et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 182 3 (2000) 636-643
51. Hibbard J.U., Tart M., and Moawad A.H. Cervical length at 16-22 weeks gestation and risk for preterm delivery. Obstet Gynecol 96 6 (2000) 972-978
52. Heath V.C., Southall T.R., Souka A.P., Elisseou A., and Nicolaides K.H. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 12 5 (1998) 312-317
53. Taipale P., and Hiilesmaa V. Sonographic measurement of uterine cervix at 18-22 weeks gestation and the risk of preterm delivery. Obstet Gynecol 92 6 (1998) 902-907
54. Guzman E.R., Walters C., Ananth C.V., et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obstet Gynecol 18 3 (2001) 204-210
55. Honest H., Bachmann L.M., Coomarasamy A., Gupta J.K., Kleijnen J., and Khan K.S. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 22 3 (2003) 305-322
56. Owen J., Yost N., Berghella V., et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 286 11 (2001) 1340-1348
57. To M.S., Skentou C., Liao A.W., Cacho A., and Nicolaides K.H. Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol 18 3 (2001) 200-203
58. Belej-Rak T., Okun N., Windrim R., Ross S., and Hannah M.E. Effectiveness of cervical cerclage for a sonographically shortened cervix: a systematic review and meta-analysis. Am J Obstet Gynecol 189 6 (2003) 1679-1687
59. Berghella V., Odibo A.O., To M.S., Rust O.A., and Althuisius S.M. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 106 1 (2005) 181-189
60. To M.S., Alfirevic Z., Heath V.C., et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 363 9424 (2004) 1849-1853
61. Berghella V., Odibo A.O., and Tolosa J.E. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 191 4 (2004) 1311-1317
62. Althuisius S.M., Dekker G.A., Hummel P., Bekedam D.J., and van Geijn H.P. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 185 5 (2001) 1106-1112
63. Althuisius S.M., Dekker G.A., Hummel P., and van Geijn H.P. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 189 4 (2003) 907-910
64. Guzman E.R., Forster J.K., Vintzileos A.M., Ananth C.V., Walters C., and Gipson K. Pregnancy outcomes in women treated with elective versus ultrasound-indicated cervical cerclage. Ultrasound Obstet Gynecol 12 (1998) 323-327
65. Groom K.M., Bennett P.R., Golara M., Thalon A., and Shennan A.H. Elective cervical cerclage versus serial ultrasound surveillance of cervical length in a population at high risk for preterm delivery. Eur J Obstet Gynecol Reprod Biol 112 2 (2004) 158-161
66. To M.S., Palaniappan V., Skentou C., Gibb D., and Nicolaides K.H. Elective cerclage vs. ultrasound-indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol 19 5 (2002) 475-477
67. Berghella V., Haas S., Chervoneva I., and Hyslop T. Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms?. Am J Obstet Gynecol 187 3 (2002) 747-751
68. Higgins S.P., Kornman L.H., Bell R.J., and Brennecke S.P. Cervical surveillance as an alternative to elective cervical cerclage for pregnancy management of suspected cervical incompetence. Aust NZ J Obstet Gynaecol 44 3 (2004) 228-232
69. Odibo A.O., Farrell C., Macones G.A., and Berghella V. Development of a scoring system for predicting the risk of preterm birth in women receiving cervical cerclage. J Perinatol 23 8 (2003) 664-667
70. Honest H., Bachmann L.M., Gupta J.K., Kleijnen J., and Khan K.S. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. Br Med J 325 7359 (2002) 301
71. Leitich H., and Kaider A. Fetal fibronectin-how useful is it in the prediction of preterm birth?. Br J Obstet Gynaecol: Int J Obstet Gynaecol 110 (2003) Suppl-70
72. Andrews W.W., Sibai B.M., Thom E.A., et al. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 101 5 Pt 1 (2003) 847-855
73. Goldenberg R.L., Klebanoff M., Carey J.C., and MacPherson C. Metronidazole treatment of women with a positive fetal fibronectin test result. Am J Obstet Gynecol 185 2 (2001) 485-486
74. Dirnberger D.R., Yoder B.A., and Gordon M.C. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies. Am J Perinatol 18 5 (2001) 267
75. Murphy D.J., Caukwell S., Joels L.A., and Wardle P. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol 187 2 (2002) 483-488
76. Gibson J.L., Macara L.M., Owen P., Young D., Macauley J., and Mackenzie F. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol 23 6 (2004) 561-566
77. Yang J.H., Kuhlman K., Daly S., and Berghella V. Prediction of preterm birth by second trimester cervical sonography in twin pregnancies. Ultrasound Obstet Gynecol 15 4 (2000) 288-291
78. Fujita M.M., Brizot M.L., Liao A.W., et al. Reference range for cervical length in twin pregnancies. Acta Obstet Gynecol Scand 81 9 (2002) 856-859
79. Souka A.P., Heath V., Flint S., Sevastopoulou I., and Nicolaides K.H. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol 94 3 (1999) 450-454
80. Newman R.B., Krombach R.S., Myers M.C., and McGee D.L. Effect of cerclage on obstetrical outcome in twin gestations with a shortened cervical length. Am J Obstet Gynecol 186 4 (2002) 634-640
81. Strauss A., Heer I.M., Janssen U., Dannecker C., Hillemanns P., and Muller-Egloff S. Routine cervical cerclage in higher order multiple gestation-does it prolong the pregnancy?. Twin Res 5 2 (2002) 67-70
82. Elimian A., Figueroa R., Nigam S., Verma U., Tejani N., and Kirshenbaum N. Perinatal outcome of triplet gestation: does prophylactic cerclage make a difference?. J Matern Fetal Med 8 3 (1999) 119-122
83. Alfirevic Z., Roberts D., and Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101 1 (2002) 6-14
84. Kujovich J.L. Thrombophilia and pregnancy complications. Am J Obstet Gynecol 191 2 (2004) 412-424
85. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 9361 (2003) 901-908
86. Clark C.A., Spitzer K.A., Nadler J.N., and Laskin C.A. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 30 10 (2003) 2127-2132
87. Empson M., Lassere M., Craig J.C., and Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99 1 (2002) 135-144
88. Lassere M., and Empson M. Treatment of antiphospholipid syndrome in pregnancy-a systematic review of randomized therapeutic trials. Thromb Res 114 5/6 (2004) 419-426
89. Gris J.C., Mercier E., Quere I., et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103 10 (2004) 3695-3699
90. Stephenson M.D., Ballem P.J., Tsang P., et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26 8 (2004) 729-734
91. Brenner B., Grabowski E.F., Hellgren M., et al. Thrombophilia and pregnancy complications. Thromb Haemost 92 4 (2004) 678-681
92. Koike T., Minakami H., Izumi A., Watanabe T., Matsubara S., and Sato I. Recurrence risk of preterm birth due to preeclampsia. Gynecol Obstet Invest 53 1 (2002) 22-27
93. Hnat M.D., Sibai B.M., Caritis S., et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 186 3 (2002) 422-426
94. Coomarasamy A., Honest H., Papaioannou S., Gee H., and Khan K.S. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 101 6 (2003) 1319-1332
95. Papageorghiou A.T., Yu C.K., Cicero S., Bower S., and Nicolaides K.H. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 12 2 (2002) 78-88
96. Coomarasamy A., Papaioannou S., Gee H., and Khan K.S. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. Obstet Gynecol 98 5 Pt 1 (2001) t-6
97. Vainio M., Kujansuu E., Iso-Mustajarvi M., and Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. Br J Obstet Gynaecol 109 2 (2002) 161-167
98. Yu C.K., Papageorghiou A.T., et al., Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks gestation. Ultrasound Obstet Gynecol 22 3 (2003) 233-239
99. Subtil D., Goeusse P., Houfflin-Debarge V., et al. Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2). Br J Obstet Gynaecol 110 5 (2003) 485-491
100. Goffinet F., Aboulker D., Paris-Llado J., et al. Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. Br J Obstet Gynaecol 108 5 (2001) 510-518
101. Tuffnell D.J., West J., and Walkinshaw S.A. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev 4 (2005)
102. Walkinshaw S.A. Very tight versus tight control for diabetes in pregnancy. Cochrane Database Syst Rev 4 (2005)
103. Walkinshaw S.A. Dietary regulation for 'gestational diabetes'. Cochrane Database Syst Rev 4 (2005)
104. Bartha J.L., Martinez-Del-Fresno P., and Comino-Delgado R. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol 109 1 (2003) 41-44
105. Vintzileos A.M., Ananth C.V., Smulian J.C., Scorza W.E., and Knuppel R.A. The impact of prenatal care in the United States on preterm births in the presence and absence of antenatal high-risk conditions. Am J Obstet Gynecol 187 5 (2002) 1254-1257
106. Heaman M.I., Sprague A.E., and Stewart P.J. Reducing the preterm birth rate: a population health strategy. J Obstet Gynecol Neonatal Nurs 30 1 (2001) 20-29 [Review, 84 Refs.]
107. Papiernik E., and Goffinet F. Prevention of preterm births, the French experience. Clin Obstet Gynecol 47 4 (2004) 755-767
108. Armson B.A., Dodds L., Haliburton S.C., Cervin C., and Rinaldo K. Impact of participation in the Halifax County Preterm Birth Prevention Project. J Obstet Gynaecol Can 25 3 (2003) 209-217
109. Carroli G., Villar J., Piaggio G., et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet 357 9268 (2001) 1565-1570
110. Villar J., Carroli G., Khan-Neelofur D., Piaggio G., and Gulmezoglu M. Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev 4 (2005)
111. Makrides M., Duley L., and Olsen S.F. Fish oil and other prostaglandin precursor supplementation during pregnancy for reducing pre-eclampsia, preterm birth, low birth weight and intrauterine growth restriction. Cochrane Database Syst Rev 4 (2005)
112. Smuts C.M., Huang M., Mundy D., Plasse T., Major S., and Carlson S.E. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101 3 (2003) 469-479
113. Olsen S.F., Secher N.J., Tabor A., Weber T., Walker J.J., and Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. Br J Obstet Gynaecol: Int J Obstet Gynaecol 107 3 (2000) 382-395
114. Crowther C.A., Hiller J.E., Pridmore B., et al., FRACOG and the ACT Study Group. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. Aust NZ J Obstet Gynaecol 39 1 (1999) 12-18
115. Vahratian A., Siega-Riz A.M., Savitz D.A., and Thorp Jr. J.M. Multivitamin use and the risk of preterm birth. Am J Epidemiol 160 9 (2004) 886-892
116. Olsen S.F. Is supplementation with marine omega-3 fatty acids during pregnancy a useful tool in the prevention of preterm birth?. Clin Obstet Gynecol 47 4 (2004) 768-774 [Discussion 881-2]
117. Rumbold A., and Crowther C.A. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev 4 (2005)
118. Rumbold A., and Crowther C.A. Vitamin C supplementation in pregnancy. Cochrane Database Syst Rev 4 (2005)
119. Sanchez-Ramos L., and Huddleston J.F. The therapeutic value of maintenance tocolysis: an overview of the evidence. Clin Perinatol 30 4 (2003) 841-854
120. Meirowitz N.B., Ananth C.V., Smulian J.C., and Vintzileos A.M. Value of maintenance therapy with oral tocolytics: a systematic review. J Matern Fetal Med 8 4 (1999) 177-183
121. Berkman N.D., Thorp Jr. J.M., Lohr K.N., et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol 188 6 (2003) 1648-1659
122. RCOG. Tocolytic drugs for women in preterm labour. Guideline no. 1B (2002), RCOG, London
123. Groom K.M., Shennan A.H., Jones B.A., Seed P., and Bennett P.R. TOCOX-a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. Br J Obstet Gynaecol 112 6 (2005) 725-730
124. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 4 (2005)
125. RCOG. Antenatal corticosteroids to prevent respiratroy distress syndrome. Guideline no. 7 (2004), RCOG, London
126. Crowther C.A., and Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 4 (2005)
127. Bloom S.L., and Leveno K.J. Corticosteroid use in special circumstances: preterm ruptured membranes, hypertension, fetal growth restriction, multiple fetuses. Clin Obstet Gynecol 46 1 (2003) 150-160
128. Boggess K.A., Bailit J.L., Singer M.E., Parisi V.M., and Mercer B.M. Projected benefits of universal or scheduled antepartum corticosteroids to prevent neonatal morbidity: a decision analysis. Am J Obstet Gynecol 193 4 (2005) 1415-1423
129. NIH Consensus Statement. Antenatal corticosteroids revisited: repeat courses. NIH Consensus Statement; 2000.
130. Guinn DA AMS. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 286 13 (2001) 1581-1587
131. Lee M.J., Davies J., Guinn D., et al. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Obstet Gynecol 103 2 (2004) 274-281
132. Thinkhamrop J., Hofmeyr G.J., Adetoro O., and Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality. Cochrane Database Syst Rev 4 (2005)
133. Dodd J.M., Crowther C.A., Cincotta R., Flenady V., and Robinson J.S. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 84 6 (2005) 526-533
134. Sanchez-Ramos L., Kaunitz A.M., and Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 105 2 (2005) 273-279
135. ACOG. Use of progesterone to reduce preterm birth. Int J Gynaecol Obstet 84 1 (2004) 93-94
136. da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 2 (2003) 419-424
137. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 24 (2003) 2379-2385
138. Spong C.Y., Meis P.J., Thom E.A., et al. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol 193 3 Pt 2 (2005) 1127-1131
139. Jones B., Groom K.M., Shennan A.H., et al. Experience of a clinic for surveillance of women at high risk of preterm delivery: cerclage rates and outcome. J Soc Gynecol Invest 11 2 Suppl (2004) 311A
140. Tudur-Smith C., Jorgensen A.L., Alfirevic Z., and Williamson P.R. Individual patient data meta-analysis: cervical stitch (cerclage) for preventing pregnancy loss in women. Br Med College: Pregnancy Childbirth 5 1 (2005) 5
141. Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis. Br Med College: Pregnancy Childbirth 5 1 (2005) 7
142. Jolly M.C., Sebire N., Harris J., Robinson S., and Regan L. Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol 96 6 (2000) 962-966
143. Smith G.C., and Pell J.P. Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study. Br Med J 323 7311 (2001) 476
144. Bloom S.L., Yost N.P., McIntire D.D., and Leveno K.J. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol 98 3 (2001) 379-385
145. Moutquin J.M. Socio-economic and psychosocial factors in the management and prevention of preterm labour. Br J Obstet Gynaecol: Int J Obstet Gynaecol 110 (2003) Suppl-60
146. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol 185 3 (2001) 643-651
147. Jackson R.A., Gibson K.A., Wu Y.W., and Croughan M.S. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 103 3 (2004) 551-563
148. Ananth C.V., Demissie K., Smulian J.C., and Vintzileos A.M. Relationship among placenta previa, fetal growth restriction, and preterm delivery: a population-based study. Obstet Gynecol 98 2 (2001) 299-306
149. Crane J.M. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol 102 5 Pt 1 (2003) 1058-1062
150. Smith G.C., Pell J.P., and Dobbie R. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. Br Med J 327 7410 (2003) 313
151. Patel R.R., Steer P., Doyle P., Little M.P., and Elliott P. Does gestation vary by ethnic group? A London-based study of over 122,000 pregnancies with spontaneous onset of labour. Int J Epidemiol 33 1 (2004) 107-113
152. Albertsen K., Andersen A.M., Olsen J., and Gronbaek M. Alcohol consumption during pregnancy and the risk of preterm delivery. Am J Epidemiol 159 2 (2004) 155-161
153. Burguet A., Kaminski M., Abraham-Lerat L., et al. The complex relationship between smoking in pregnancy and very preterm delivery. Results of the Epipage study. Br J Obstet Gynaecol 111 3 (2004) 258-265
154. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., and Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 189 1 (2003) 139-147
155. Harrington K., Carpenter R.G., Goldfrad C., and Campbell S. Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 104 6 (1997) 674-681